Skip to content

A Novel and Cost-effective Protein-based Vaccine Against Pneumococcal Invasive Disease

A tripartite pneumococcal vaccine that provides universal coverage through antibody- and cell-mediated responses

Published: 16th October 2020
A Novel and Cost-effective Protein-based Vaccine Against Pneumococcal Invasive Disease
Source: https://stock.adobe.com/uk/215843357
Patents
  • A patent titled “A novel and potent yet cheaper vaccine against pneumococcal disease” was filed in 2020
IP Status
  • Patent application submitted
Seeking
  • Commercial partner
  • Development partner